contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


chordate-initiates-market-introduction-of-the-migraine-indication-in-saudi-arabia

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

Chordate Medical Holding is a medical technology company that has developed, patented and CE-marked a nerve-modulating treatment technique for chronic migraine and chronic nasal congestion (rhinitis), Kinetic Oscillation Stimulation (KOS). The company sells its products to treating clinics in selected European markets, Israel and Saudi Arabia, with the aim of increasing its presence in the global market.

Chordate Medical Holding

The first demonstration with Ozilia® Migraine was conducted yesterday at King Abdulaziz Medical City, a National Guard hospital in Jeddah. The company's distributor, Janin Medical, has been ...

<div class="mfn-preamble"><p><strong>The first demonstration with Ozilia® Migraine was conducted yesterday at King Abdulaziz Medical City, a National Guard hospital in Jeddah. The company's distributor, Janin Medical, has been preparing for the launch since this spring – and this marks the first step after receiving market approval from the SFDA (Saudi Food and Drug Authority) a week ago.</strong></p></div><div class="mfn-body"><p>King Abdulaziz Medical City, with 751 beds, is a significant part of the Ministry of National Guard Health Affairs' approximately 3,000+ beds across the kingdom, responsible for the healthcare of National Guard personnel and their families. Out of the country’s nearly 500 hospitals, about 335 are publicly owned or belong to various defense ministries, with the remainder being privately operated. The demonstration was carried out at the department of Dr. Abdullah Attar, head of neuroscience, by Janin’s sales manager Mohamad Ibrahim and Chordate’s General Manager Alain Durante, based in Jeddah.</p><p>"It’s a great feeling to finally get started after a period of preparation for the migraine introduction, and that we managed to secure product registration faster than expected," says Alain Durante, Chordate General Manager, MEA area.</p></div><div class="mfn-footer mfn-contacts mfn-69b71597c32e"><p><strong class="mfn-heading-1">For more information, please contact:</strong><br>Anders Weilandt, CEO<br><a rel="noopener" href="mailto:anders.weilandt@chordate.com">anders.weilandt@chordate.com</a><br>Cell: +46 733-874277</p></div><div class="mfn-footer mfn-about mfn-3b44868689f4"><p><strong class="mfn-heading-1">About Chordate</strong><br>Chordate Medical Holding AB (publ) is a medical technology company that has developed, patented and CE-marked Ozilia® Migraine, a neuromodulation and drug-free treatment technology for chronic migraine and chronic rhinitis. The treatment has clinically proven efficacy according to a recent study, and is marketed in selected markets in the EU and the Middle East. Chordate Medical is listed on Nasdaq First North Growth Market Stockholm (ticker: CMH). Read more at <a rel="noopener" href="https://www.chordate.com/en/">www.chordate.com</a></p><p>The company's Certified Adviser on Nasdaq First North Growth Market Stockholm is Vator Securities AB.<em><br></em><br><em>N.B. The English text is an in-house translation of the original Swedish text. Should there be any disparities between the Swedish and the English text, the Swedish text shall prevail.</em></p></div><div class="mfn-footer mfn-attachment mfn-attachment-image"><p><strong class="mfn-heading-1">Image Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/3e3b7f07-db77-4354-adaa-f6c71eaebfbb/ozilia-demonstration-at-king-abdulaziz-medical-city.jpeg">Ozilia Demonstration At King Abdulaziz Medical City</a></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/5cf40e38-b602-48de-aaca-c2996994711a/chordate-initiates-market-introduction-of-the-migraine-indication-in-saudi-arabia.pdf" class="mfn-generated mfn-primary">Chordate initiates market introduction of the migraine indication in Saudi Arabia</a></p></div>

Chordate initiates market introduction of the migraine indication in Saudi Arabia

Pysy ajantasalla Inderesin uutiskirjeillä